Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analysis of structural variations in the genome using optical genome mapping. This technology is vital for deciphering genetic variations and their functional roles. The Saphyr platform includes the Saphyr instrument, a device capable of imaging single molecules; the Saphyr Chip, a disposable component equipped with nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits,…
| Price | $1.73 |
|---|---|
| Market cap | $19.79M |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Exchange | NASDAQ |
| 52-week range | 1-2.23 |
| Beta | 1.65 |
Explore BNGO's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.